On July 8, Alibaba Health rose 3.37% in regular trading, trading at HKD 3.37/share, with turnover of HKD 235 million, recovering the prior session's decline.

On the news front, the company recently announced it will seek shareholder approval at its annual general meeting to authorize repurchase of up to 10% of issued shares. The company also declared a final and special dividend totaling RMB 0.1945 per share, sending a positive shareholder return signal. Additionally, the fiscal year results showed revenue of RMB 34.255 billion with net profit surging 35.2% year-over-year, providing fundamental support for the rebound.

At the sector level, parent company Alibaba-W surged 10.33% on the same day, while medical e-commerce peers rallied broadly, with PA Good Doctor up 3.88% and JD Health up 1.16%, creating a positive linkage effect across the Internet and Direct Marketing Retail sector.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)